Busol 0.004 mg/ml solution for injection for cattle, horses, rabbits
Busol 0.004 mg/ml solution for injection for cattle, horses, rabbits
Authorised
- Buserelin acetate
Product identification
Medicine name:
BUSOL 0,0040mg/ml ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Busol 0.004 mg/ml solution for injection for cattle, horses, rabbits
Active substance:
- Buserelin acetate
Target species:
-
Cattle
-
Horse
-
Rabbit
Route of administration:
-
Intramuscular use
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Buserelin acetate0.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal0day
-
Milk0day
-
-
Horse
-
Meat and offal0day
-
Milk0day
-
-
Rabbit
-
Meat and offal0day
-
-
-
Intravenous use
-
Horse
-
Meat and offal0day
-
Milk0day
-
-
-
Subcutaneous use
-
Horse
-
Meat and offal0day
-
Milk0day
-
-
Rabbit
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH01CA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Available in:
-
Greece
Package description:
- Pack of 5 injection vials (glass type I) each containing 10 ml in a cardboard carton.Injection vial closed with a bromobutyl rubber stopper and sealed with an aluminium crimp cap.
- Pack of 50 (10x5) injection vials (multipack).Injection vial closed with a bromobutyl rubber stopper and sealed with an aluminium crimp cap.
- Pack of 100 (20x5) injection vials (multipack).Injection vial closed with a bromobutyl rubber stopper and sealed with an aluminium crimp cap.
- Pack of 250 (50x5) injection vials (multipack).Injection vial closed with a bromobutyl rubber stopper and sealed with an aluminium crimp cap.
- Pack of 500 (100x5) injection vials (multipack).Injection vial closed with a bromobutyl rubber stopper and sealed with an aluminium crimp cap.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- T. P. Whelehan Son & Co. Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- aniMedica GmbH
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 99126/03-10-2023/K-0174301
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0213/001
Concerned member states:
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Estonia
-
Finland
-
Greece
-
Hungary
-
Iceland
-
Italy
-
Latvia
-
Lithuania
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 11/01/2026
Greek (PDF)
Published on: 16/07/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 16/07/2024
ie-puar-mr-iev0213001-busol-0004-mgml-solution-for-injection-for-cattle--en.pdf
English (PDF)
Download Published on: 11/01/2026